study | n | Age (∅) | FU (y) | comorbidities | function | dislocation (%) | dissociation (%) | time (min) | other |
|---|
Chalmers [5] | 18 | 64 | 3.0 | / | HHS 82 | 3/18 (17%) | 0% | / | 2 PPF |
Moreta [6] | 10 | 79 | 3.5 | CCI 4.3 | HHS 71 | 10% | 0% | / | / |
Wegrzyn [7] | 28 | 82 | 3.5 | 56/44% ASA 3/2 | HHS 88 | 0 | 0 | 107’ | / |
Bellova | 33 | 79 | 2.5 | ASA 2.72 CCI 5.1 | HHS 59 WOMAC 60 | 2/26 (7.7%) | 1/24 (4.2%) | 124′ | 1 infection 1 PPF |
- ASA American Society of Anesthesiologists (score); CCI Charlson Comorbidity Index; FU follow-up; HHS Harris Hip Score, min minutes; n number; PPF periprosthetic fracture; WOMAC Western Ontario and McMasters University Osteoarthritis Index; y years; ∅ average
